Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Replimune Group Inc (NQ: REPL)
22.16   -0.79 (-3.44%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jul 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 108,200
Open 23.16
Bid (Size) 22.08 (3)
Ask (Size) 22.16 (5)
Prev. Close 22.95
Today's Range 21.57 - 23.27
52wk Range 8.580 - 26.22
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+51.57%
+51.57%
1 Month
+11.02%
+11.02%
3 Month
+127.05%
+127.05%
6 Month
+51.57%
+51.57%
1 Year
+58.29%
+58.29%
Top News
More News
Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
from GlobeNewswire News Releases
Replimune Announces Pricing of Upsized Public Offering
from GlobeNewswire News Releases
More News
Read More
Replimune Announces Proposed Public Offering
from GlobeNewswire News Releases
Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune’s Ongoing Registration-Directed Clinical Trials with RP1
from GlobeNewswire News Releases
The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight
category CLDX , Trading Ideas , ABBV , and 23 more.
from Benzinga
Benzinga's Top Upgrades, Downgrades For July 1, 2020
category SJI , SAIL , Penny Stocks , and 40 more.
from Benzinga
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
category GTH , Trading Ideas , CRDF , and 44 more.
from Benzinga
Stocks That Hit 52-Week Highs On Monday
category SHLL , NVAX , QDEL , and 67 more.
from Benzinga
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
category PLRX , ABBV , ALT , and 49 more.
from Benzinga
64 Biggest Movers From Yesterday
category NNVC , ALBO , ESTE , and 73 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.